MRC2 and rectal neoplasm: The biomarker signature was comprised of seven proteins (CADM1, LGALS3BP, HYOU1, FN1, VTN, LRG1, and MRC2) (Fig4A, Appendix Table S4) that could predict the localization of rectal tumors especially well (86% of subjects with rectal cancer).